TMCI
Income statement / Annual
Last year (2024), Treace Medical Concepts, Inc.'s total revenue was $209.36 M,
an increase of 11.89% from the previous year.
In 2024, Treace Medical Concepts, Inc.'s net income was -$55.74 M.
See Treace Medical Concepts, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$209.36 M |
$187.12 M |
$141.84 M |
$94.42 M |
$57.37 M |
$39.42 M |
| Cost of Revenue |
$41.09 M
|
$35.18 M
|
$27.52 M
|
$16.89 M
|
$12.47 M
|
$7.63 M
|
| Gross Profit |
$168.26 M
|
$151.94 M
|
$114.32 M
|
$77.53 M
|
$44.90 M
|
$31.79 M
|
| Gross Profit Ratio |
0.8
|
0.81
|
0.81
|
0.82
|
0.78
|
0.81
|
| Research and Development Expenses |
$20.59 M
|
$15.44 M
|
$13.58 M
|
$10.20 M
|
$5.85 M
|
$5.07 M
|
| General & Administrative Expenses |
$55.72 M
|
$47.03 M
|
$33.00 M
|
$18.43 M
|
$6.54 M
|
$4.46 M
|
| Selling & Marketing Expenses |
$147.64 M
|
$140.89 M
|
$104.57 M
|
$65.41 M
|
$31.65 M
|
$25.79 M
|
| Selling, General & Administrative Expenses |
$203.36 M
|
$187.93 M
|
$137.57 M
|
$83.84 M
|
$38.19 M
|
$30.25 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.99 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$223.95 M
|
$203.37 M
|
$149.16 M
|
$94.04 M
|
$44.04 M
|
$35.32 M
|
| Cost And Expenses |
$265.05 M
|
$238.55 M
|
$176.68 M
|
$110.93 M
|
$56.51 M
|
$42.95 M
|
| Interest Income |
$4.88 M
|
$6.73 M
|
$1.31 M
|
$18.00 K
|
$0.00
|
$111.00 K
|
| Interest Expense |
$5.26 M
|
$5.17 M
|
$4.40 M
|
$4.06 M
|
$4.52 M
|
$841.00 K
|
| Depreciation & Amortization |
$8.42 M
|
$5.35 M
|
$2.13 M
|
$685.00 K
|
$1.21 M
|
$793.00 K
|
| EBITDA |
-$42.07 M |
-$39.01 M |
-$36.28 M |
-$15.81 M |
$2.07 M |
-$2.63 M |
| EBITDA Ratio |
-0.2
|
-0.21
|
-0.26
|
-0.17
|
0.04
|
-0.07
|
| Operating Income Ratio |
-0.27
|
-0.27
|
-0.25
|
-0.17
|
0.01
|
-0.09
|
| Total Other Income/Expenses Net |
-$55.00 K
|
$1.90 M
|
-$7.97 M
|
-$4.04 M
|
-$4.52 M
|
-$730.00 K
|
| Income Before Tax |
-$55.74 M
|
-$49.53 M
|
-$42.82 M
|
-$20.55 M
|
-$3.67 M
|
-$4.27 M
|
| Income Before Tax Ratio |
-0.27
|
-0.26
|
-0.3
|
-0.22
|
-0.06
|
-0.11
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$55.74 M
|
-$49.53 M
|
-$42.82 M
|
-$20.55 M
|
-$3.67 M
|
-$4.27 M
|
| Net Income Ratio |
-0.27
|
-0.26
|
-0.3
|
-0.22
|
-0.06
|
-0.11
|
| EPS |
-0.9 |
-0.81 |
-0.77 |
-0.38 |
-0.0842 |
-0.0998 |
| EPS Diluted |
-0.9 |
-0.81 |
-0.77 |
-0.38 |
-0.0842 |
-0.0998 |
| Weighted Average Shares Out |
$62.11 M
|
$60.85 M
|
$55.28 M
|
$54.18 M
|
$51.17 M
|
$51.17 M
|
| Weighted Average Shares Out Diluted |
$62.11 M
|
$60.85 M
|
$55.28 M
|
$54.18 M
|
$51.17 M
|
$51.17 M
|
| Link |
|
|
|
|
|
|
